Amazon (AMZN) Will No Longer Test Employees for Marijuana

Amazon (NASDAQ: AMZN) announced that it adjusted its drug testing policy to no longer test for the use of marijuana.

In a blog post published today, the e-commerce giant said:

“In the past, like many employers, we’ve disqualified people from working at Amazon if they tested positive for marijuana use. However, given where state laws are moving across the U.S., we’ve changed course. We will no longer include marijuana in our comprehensive drug screening program for any positions not regulated by the Department of Transportation, and will instead treat it the same as alcohol use. We will continue to do impairment checks on the job and will test for all drugs and alcohol after any incident.”

Given this change, the company’s public policy team will start “actively supporting” the Marijuana Opportunity Reinvestment and Expungement Act of 2021 (MORE Act) as this issue is “bigger than Amazon.”

The company endorses the law and has asked other companies to join them in lobbying the policymakers to swiftly pass this law.

You May Also Be Interested In

• Evercore survey shows Meta and Google lead digital ad spending
• Constellation Energy stock climbs on Amazon nuclear power deal
• Marfrig unit cancels tender offer for $467M in senior notes